Investor Presentation
Investor Presentation
Melbourne, Sep 6, 2021 AEST (ABN Newswire) - Anatara Lifesciences Limited (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in humans and animals, is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr. Steven Lydeamore, will present today to investors.

To view the Presentation, please visit:
https://abnnewswire.net/lnk/20846ZE6


About Anatara Lifesciences Limited

Anatara Lifesciences ASX ANRAnatara Lifesciences Limited (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing products for animal and human health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders. For more information, please visit www.anataralifesciences.com.

    


Contact

Steven Lydeamore
CEO, Anatara Lifesciences Ltd
+61 (0) 438 027 172
slydeamore@anatara.com

Eric Kuret
Market Eye
+61 (0) 417 311 335
eric.kuret@marketeye.com.au



Related Companies

Anatara Lifesciences Limited

ABN Newswire This Page Viewed:  (Last 7 Days: 27) (Last 30 Days: 153) (Since Published: 1548)